Relief Therapeutics Holding AG (RLFTF)

[tcm55]

I have recently re-read some info on Primary and Secondary Outcomes from Clinical Trials related to COVID-19.
There are few with the High Goals Set by RLF-100 (Or by whatever Brand name)... None with Interim Data matching RLF-100.
Some are weak and/or using shotguns picking 'outcome' targets.
Most treatments have had harmful side effects besides being relatively ineffective. Data and Patient successes have been meager, barely surpassing SOC.

Yes, RLF shareholders have suffered serious dilution paying for 'Development' of RLF-100, BUT we still own the PATENT. That's the JEWEL of Any Deal and Any future Manufacturing / Distribution / Sales Partnerships. IMO.


All development costs under the agreement are paid by Relief, providing NeuroRx with non dilutive development capital through drug approval"

Zyesami"
Relief also holds a patent issued in the United States and various other countries covering potential formulations of RLF-100TM"...

formulations = INHALER...




God Bless MLK and his Legacy.

...GLTA...